Cargando…

Treatment-resistant depression in adolescents: is the addition of cognitive behavioral therapy of benefit?

BACKGROUND: Many young people with major depression fail first-line treatments. Treatment-resistant depression has various definitions in the literature but typically assumes nonresponse to medication. In young people, cognitive behavioral therapy (CBT) is the recommended first-line intervention, th...

Descripción completa

Detalles Bibliográficos
Autores principales: Hetrick, Sarah E, Cox, Georgina R, Merry, Sally N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218778/
https://www.ncbi.nlm.nih.gov/pubmed/22114540
http://dx.doi.org/10.2147/PRBM.S13780
_version_ 1782216727617077248
author Hetrick, Sarah E
Cox, Georgina R
Merry, Sally N
author_facet Hetrick, Sarah E
Cox, Georgina R
Merry, Sally N
author_sort Hetrick, Sarah E
collection PubMed
description BACKGROUND: Many young people with major depression fail first-line treatments. Treatment-resistant depression has various definitions in the literature but typically assumes nonresponse to medication. In young people, cognitive behavioral therapy (CBT) is the recommended first-line intervention, thus the definition of treatment resistance should be expanded. Therefore, our aim was to synthesize the existing evidence of any interventions for treatment-resistant depression, broadly defined, in children and adolescents and to investigate the effectiveness of CBT in this context. METHODS: We used Cochrane Collaboration methodology, with electronic searches of Medline, PsycINFO, Embase, and the Cochrane Depression Anxiety and Neurosis Group trials registers. Only randomized controlled trials were included, and were assessed for risk of bias. Meta- analysis was undertaken where possible and appropriate. RESULTS: Of 953 articles retrieved, four trials were eligible for inclusion. For one study, only the trial registration document was available, because the study was never completed. All other studies were well conducted with a low risk of bias, although one study had a high dropout rate. Two studies assessed the effect of adding CBT to medication. While an assertive trial of antidepressants does appear to lead to benefit, when compared with placebo, there was no significant advantage, in either study, or in a meta-analysis of data from these trials, that clearly demonstrated an additional benefit of CBT. The third trial showed little advantage of a tricyclic antidepressant over placebo in the context of an inpatient admission. CONCLUSION: Few randomized controlled trials have investigated interventions for treatment-resistant depression in young people, and results from these show modest benefit from antidepressants with no additional benefit over medication from CBT. Overall, there is a lack of evidence about effective interventions to treat young people who have failed to respond to evidence-based interventions for depression. Research in this area is urgently required.
format Online
Article
Text
id pubmed-3218778
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-32187782011-11-23 Treatment-resistant depression in adolescents: is the addition of cognitive behavioral therapy of benefit? Hetrick, Sarah E Cox, Georgina R Merry, Sally N Psychol Res Behav Manag Review BACKGROUND: Many young people with major depression fail first-line treatments. Treatment-resistant depression has various definitions in the literature but typically assumes nonresponse to medication. In young people, cognitive behavioral therapy (CBT) is the recommended first-line intervention, thus the definition of treatment resistance should be expanded. Therefore, our aim was to synthesize the existing evidence of any interventions for treatment-resistant depression, broadly defined, in children and adolescents and to investigate the effectiveness of CBT in this context. METHODS: We used Cochrane Collaboration methodology, with electronic searches of Medline, PsycINFO, Embase, and the Cochrane Depression Anxiety and Neurosis Group trials registers. Only randomized controlled trials were included, and were assessed for risk of bias. Meta- analysis was undertaken where possible and appropriate. RESULTS: Of 953 articles retrieved, four trials were eligible for inclusion. For one study, only the trial registration document was available, because the study was never completed. All other studies were well conducted with a low risk of bias, although one study had a high dropout rate. Two studies assessed the effect of adding CBT to medication. While an assertive trial of antidepressants does appear to lead to benefit, when compared with placebo, there was no significant advantage, in either study, or in a meta-analysis of data from these trials, that clearly demonstrated an additional benefit of CBT. The third trial showed little advantage of a tricyclic antidepressant over placebo in the context of an inpatient admission. CONCLUSION: Few randomized controlled trials have investigated interventions for treatment-resistant depression in young people, and results from these show modest benefit from antidepressants with no additional benefit over medication from CBT. Overall, there is a lack of evidence about effective interventions to treat young people who have failed to respond to evidence-based interventions for depression. Research in this area is urgently required. Dove Medical Press 2011-08-01 /pmc/articles/PMC3218778/ /pubmed/22114540 http://dx.doi.org/10.2147/PRBM.S13780 Text en © 2011 Hetrick et al, publisher and licensee Dove Medical Press Ltd This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Review
Hetrick, Sarah E
Cox, Georgina R
Merry, Sally N
Treatment-resistant depression in adolescents: is the addition of cognitive behavioral therapy of benefit?
title Treatment-resistant depression in adolescents: is the addition of cognitive behavioral therapy of benefit?
title_full Treatment-resistant depression in adolescents: is the addition of cognitive behavioral therapy of benefit?
title_fullStr Treatment-resistant depression in adolescents: is the addition of cognitive behavioral therapy of benefit?
title_full_unstemmed Treatment-resistant depression in adolescents: is the addition of cognitive behavioral therapy of benefit?
title_short Treatment-resistant depression in adolescents: is the addition of cognitive behavioral therapy of benefit?
title_sort treatment-resistant depression in adolescents: is the addition of cognitive behavioral therapy of benefit?
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218778/
https://www.ncbi.nlm.nih.gov/pubmed/22114540
http://dx.doi.org/10.2147/PRBM.S13780
work_keys_str_mv AT hetricksarahe treatmentresistantdepressioninadolescentsistheadditionofcognitivebehavioraltherapyofbenefit
AT coxgeorginar treatmentresistantdepressioninadolescentsistheadditionofcognitivebehavioraltherapyofbenefit
AT merrysallyn treatmentresistantdepressioninadolescentsistheadditionofcognitivebehavioraltherapyofbenefit